Remove Biobanking Remove Genome Project Remove Research Remove Scientist
article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

Both long- and short-read sequencing today is faster, more affordable, and highly accurate, providing researchers with deep insights to fuel research. 2023 is set to usher in a new era of genomics, and here are five areas where we should see significant advances. So, when it comes to proteomics, accuracy is vital.

Genome 124
article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

One of the reasons is because researchers now have far more genetic data to work with than was ever previously possible. The cost of testing per human genome in 2006 was approximately $14 million , and in less than two decades, an average consumer-purchased genetic test costs $100.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why genomic healthcare data matters in the development of new therapies 

Drug Discovery World

One might argue that this all started getting exciting with the launch of the Human Genome Project, which the National Human Genome Research Institute consider to be one of the greatest scientific feats in history 1. With Revio, researchers will be able to access that same great chemistry, but at a much larger scale.” .

Genome 98
article thumbnail

Q&A: Gene therapy opportunities from long-read sequencing 

Drug Discovery World

To develop safe and effective gene therapies, researchers need confidence that genomic data is both complete and accurate. This considerable magnitude of difference in read length affords researchers a more complete and accurate view of genomic variation.